2022
DOI: 10.1016/j.nantod.2022.101600
|View full text |Cite
|
Sign up to set email alerts
|

Near-infrared photoactivatable semiconducting polymer nanocomplexes with bispecific metabolism interventions for enhanced cancer immunotherapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
23
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

4
3

Authors

Journals

citations
Cited by 40 publications
(23 citation statements)
references
References 71 publications
0
23
0
Order By: Relevance
“…ROS‐cleavable linker with terminal carboxyl groups on each side was synthesized according to previous work. [ 7c ]…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…ROS‐cleavable linker with terminal carboxyl groups on each side was synthesized according to previous work. [ 7c ]…”
Section: Methodsmentioning
confidence: 99%
“…The evaluations of ATP, CRT, and HMGB1 levels in tumor tissues were conducted according to previous work. [ 7d ]…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…PDT is a promising approach for cancer therapy through generating ROS. In addition to directly inducing cell death, the generated ROS during PDT can destroy ROS-responsive elements in gene carriers to achieve controlled gene delivery in targeted sites, thus regulating gene expression.…”
Section: Photodynamic Regulation Of Gene Expressionmentioning
confidence: 99%
“…Light-responsive nanosystems provide a powerful tool for specific delivery of drugs into target sites. These nanosystems enable on-demand release of cargos upon the stimulation by light and thus display high selectivity and specificity . Ultraviolet/visible light are generally utilized for causing the release of drugs from photoresponsive nanosystems, while their limited tissue penetrating ability and potential phototoxicity should be concerned. Near-infrared (NIR) light showing much greater tissue penetration depths and negligible damages to normal tissues have been adopted to achieve controlled drug release. Currently, NIR light-responsive nanosystems have been extensively explored for precision cancer therapy. Therefore, specific delivery of metastasis inhibitors to targeting sites using NIR light-responsive nanosystems should be a promising strategy for effective tumor metastasis, which however has been poorly reported.…”
Section: Introductionmentioning
confidence: 99%